HDAC1/2 inhibitor therapy improves multiple organ systems in aged mice

Bibliographic Details
Title: HDAC1/2 inhibitor therapy improves multiple organ systems in aged mice
Authors: Alessandra Tammaro, Eileen G. Daniels, Iman M. Hu, Kelly C. ‘t Hart, Kim Reid, Rio P. Juni, Loes M. Butter, Goutham Vasam, Rashmi Kamble, Aldo Jongejan, Richard I. Aviv, Joris J.T.H. Roelofs, Eleonora Aronica, Reinier A. Boon, Keir J. Menzies, Riekelt H. Houtkooper, Georges E. Janssens
Source: iScience, Vol 27, Iss 1, Pp 108681- (2024)
Publisher Information: Elsevier, 2024.
Publication Year: 2024
Collection: LCC:Science
Subject Terms: Drugs, Molecular biology, Epigenetics, Omics, Transcriptomics, Science
More Details: Summary: Aging increases the risk of age-related diseases, imposing substantial healthcare and personal costs. Targeting fundamental aging mechanisms pharmacologically can promote healthy aging and reduce this disease susceptibility. In this work, we employed transcriptome-based drug screening to identify compounds emulating transcriptional signatures of long-lived genetic interventions. We discovered compound 60 (Cmpd60), a selective histone deacetylase 1 and 2 (HDAC1/2) inhibitor, mimicking diverse longevity interventions. In extensive molecular, phenotypic, and bioinformatic assessments using various cell and aged mouse models, we found Cmpd60 treatment to improve age-related phenotypes in multiple organs. Cmpd60 reduces renal epithelial-mesenchymal transition and fibrosis in kidney, diminishes dementia-related gene expression in brain, and enhances cardiac contractility and relaxation for the heart. In sum, our two-week HDAC1/2 inhibitor treatment in aged mice establishes a multi-tissue, healthy aging intervention in mammals, holding promise for therapeutic translation to promote healthy aging in humans.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2589-0042
Relation: http://www.sciencedirect.com/science/article/pii/S258900422302758X; https://doaj.org/toc/2589-0042
DOI: 10.1016/j.isci.2023.108681
Access URL: https://doaj.org/article/42cc145abf8d478f88355c37c49e69d9
Accession Number: edsdoj.42cc145abf8d478f88355c37c49e69d9
Database: Directory of Open Access Journals
More Details
ISSN:25890042
DOI:10.1016/j.isci.2023.108681
Published in:iScience
Language:English